Clinical Trial Update: Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the impact of inhaled nitric oxide on invasively derived pulmonary pressures in patients with pulmonary arterial hypertension…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2018-09-24